Innovating Works

VISMEDERI SRL

Desconocido
VIVACE: Management of avian influenza in a vaccination context While outbreaks of highly pathogenic avian influenza viruses (HPAIV) in Europe used to be rare and geographically contained, the situation h...
2024-07-08 - 2028-11-30 | Financiado
Inno4Vac: Innovations to accelerate vaccine development and manufacture VISMEDERI SRL participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
INDIGO: Effective and Affordable Flu Vaccines for the World VISMEDERI SRL participó en un H2020: H2020-SC1-BHC-2018-2020 Despite the availability of flu vaccines for decades, influenza is still an important disease in both developing and developed countries wit...
2019-12-13 - 2025-03-31 | Financiado
PRONKJEWAIL: Protecting patients with enhanced susceptibility to infections VISMEDERI SRL participó en un H2020: H2020-MSCA-COFUND-2015 The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Progr...
2016-03-31 - 2021-08-31 | Financiado
BIOVACSAFE: Biomarkers For Enhanced Vaccine Safety VISMEDERI SRL participó en un FP6: BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised...
2012-03-01 - 2018-08-31 | Financiado
ADITEC: Advanced Immunization Technologies VISMEDERI SRL participó en un FP7: Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious...
Financiado
BIOVACSAFE: Biomarkers For Enhanced Vaccine Safety VISMEDERI SRL participó en un FP7: BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.